Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
Cintas Corporation’s proposed $5.2 billion all‑cash acquisition of rival UniFirst marks the most consequential consolidation move in North American uniform rental and route-based business...
```html Strategic imperative for scale and growth is reshaping boardroom decision-making, according to Anu Aiyengar, JPMorgan's Global Head of Advisory and Mergers & Acquisitions. As geopolitical and...
Eli Lilly’s $1.2 billion all-cash acquisition of Ventyx Biosciences is a targeted move to secure a differentiated, oral NLRP3 franchise and expand its footprint across cardiometabolic,...
European private equity giant CVC Capital Partners has emerged as the frontrunner to acquire a majority stake in Hyderabad-based technology and AI services firm ValueLabs, at a valuation of $1–1.2...
Buyout firm Advent International is in advanced talks with InPost SA founder-CEO Rafał Brzoska and Czech investment group PPF over a consortium bid to take the Amsterdam-listed parcel locker...
Blackstone’s plan to raise a **$2.6 billion debt package** to merge **MacLean Power Systems** with **Power Grid Components** is a textbook example of how large-cap private equity is repositioning...
The decision by the estate of Microsoft co-founder Paul Allen to sell its stake in Cercano Management, transforming the firm into a fully employee-owned $10.5 billion wealth manager, is a small...
```html Munich-based investment holding Armira has signed an agreement to acquire a majority stake in Viabus, the Netherlands' leading guided tour operator specializing in senior and young-senior...
Germany’s Henkel AG has submitted a takeover offer for U.S.-listed haircare group Olaplex Holdings Inc., creating a potential exit path for private equity owner Advent International after a...
```html AbbVie Inc. is in advanced talks to acquire Revolution Medicines, a clinical-stage precision oncology company, in a deal valued at approximately $20 billion or more—a significant premium to...
